Vor BioPharma Surpasses $1 Billion Valuation After IPO
On February 5th, Vor BioPharma, a cell therapy company focusing on developing therapies for Acute Myeloid Leukemia (AML), began trading on the Nasdaq under the ticker symbol VOR. The company’s …
Read More